What is NeuraLight?
Founded in 2021 and based in Austin, Texas, NeuraLight is dedicated to improving the lives of individuals suffering from neurological conditions. The company's core mission involves the digitization of neurological analysis and treatment processes, aiming to provide more accessible and effective solutions. This strategic focus positions NeuraLight at the intersection of healthcare innovation and technology, addressing a critical need for advanced neurological care.
How much funding has NeuraLight raised?
NeuraLight has raised a total of $30.5M across 2 funding rounds:
Angel/Seed
$5.5M
Series A
$25M
Angel/Seed (2021): $5.5M with participation from Operator Partners, Tuesday, VSC Ventures, Kli, and MSAD
Series A (2022): $25M led by Breyer Capital, VSC Ventures, Chris Mansi, David Golan, Lily Sarafan, Koch Disruptive Technologies, and Samsung NEXT
Key Investors in NeuraLight
Breyer Capital
Breyer Capital is an independent global venture capital and private equity investor founded by Jim Breyer in 2006, focusing on long-term, idea-driven investments. The firm aims to catalyze high-impact entrepreneurs by leveraging insights from a network of world-class investors and a belief in the transformative power of artificial intelligence and machine learning.
VSC Ventures
VSC Ventures is a venture capital firm that invests in early-stage companies. Their investment focus often aligns with disruptive technologies and innovative business models.
Samsung NEXT
Samsung NEXT, founded in 2012, provides software and services to complement Samsung's global hardware footprint, investing in and nurturing startups that align with Samsung's strategic vision.
What's next for NeuraLight?
The recent major strategic investment signifies a pivotal moment for NeuraLight, likely enabling the company to accelerate its product development, expand its research initiatives, and scale its operations. This capital infusion is expected to fuel further innovation in digitizing neurological diagnostics and therapeutics, potentially leading to broader market penetration and enhanced patient outcomes. The company's trajectory suggests a move towards solidifying its position as a leader in the health technology space, with a strong emphasis on leveraging technology for neurological health.
See full NeuraLight company page